HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Sage
SAN FRANCISCO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Sage Therapeutics, Inc. (NASDAQ: SAGE) investors who suffered substantial losses to...
Reed Kathrein Hagens Berman Sage Therapeutics Inc Sage Therapeutics New Drug Application Business Daily
Source: globenewswire.com